Merck & Co Inc [MRK] stock is trading at $110.99, up 2.20%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MRK shares have gain 5.44% over the last week, with a monthly amount glided 12.19%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Merck & Co Inc [NYSE: MRK] stock has seen the most recent analyst activity on January 08, 2026, when Wolfe Research upgraded its rating to an Outperform but kept the price target unchanged to $135 for it. Previously, BMO Capital Markets upgraded its rating to Outperform on December 18, 2025, and kept the price target unchanged to $130. On November 24, 2025, upgrade upgraded it’s rating to Overweight but maintained its price target of $125 on the stock. Scotiabank started tracking the stock assigning a Sector Outperform rating and suggested a price target of $105 on November 13, 2025. Berenberg downgraded its rating to Hold for this stock on September 17, 2025, but kept the price target unchanged to $90. In a note dated May 14, 2025, Citigroup downgraded a Neutral rating on this stock but restated the target price of $84.
Merck & Co Inc [MRK] stock has fluctuated between $73.31 and $111.46 over the past year. Currently, Wall Street analysts expect the stock to reach $118.78 within the next 12 months. Merck & Co Inc [NYSE: MRK] shares were valued at $110.99 at the most recent close of the market. An investor can expect a potential return of 7.02% based on the average MRK price forecast.
Analyzing the MRK fundamentals
Merck & Co Inc [NYSE:MRK] reported sales of 63.90B for the trailing twelve months, which represents a growth of 2.80%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.36%, Pretax Profit Margin comes in at 0.34%, and Net Profit Margin reading is 0.3%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.39 and Total Capital is 0.28. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.8.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 109.19 points at the first support level, and at 107.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 112.84, and for the 2nd resistance point, it is at 114.70.
Ratios To Look Out For
For context, Merck & Co Inc’s Current Ratio is 1.66. In addition, the Quick Ratio stands at 1.44 and the Cash Ratio stands at 0.63. Considering the valuation of this stock, the price to sales ratio is 4.31, the price to book ratio is 5.32 and price to earnings (TTM) ratio is 14.68.
Transactions by insiders
Recent insider trading involved Downing Cristal N, Chief Comm. & Public Afrs Ofcr, that happened on Nov 10 ’25 when 7085.0 shares were sold. Officer, CRISTAL DOWNING completed a deal on Nov 10 ’25 to buy 7085.0 shares. Meanwhile, EVP,Chief Info&Digital Officer Williams David Michael sold 8614.0 shares on Nov 03 ’25.
